Veeva Systems (NYSE:VEEV – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Needham & Company LLC in a research note issued on Thursday,Benzinga reports. They currently have a $270.00 target price on the technology company’s stock. Needham & Company LLC’s price objective indicates a potential upside of 51.10% from the company’s previous close.
Several other brokerages also recently issued reports on VEEV. William Blair reiterated an “outperform” rating on shares of Veeva Systems in a research report on Tuesday, March 10th. Zacks Research downgraded Veeva Systems from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 14th. UBS Group lifted their price objective on Veeva Systems from $200.00 to $220.00 and gave the company a “neutral” rating in a research report on Thursday, March 5th. Wells Fargo & Company reiterated an “overweight” rating and issued a $320.00 price objective on shares of Veeva Systems in a research report on Thursday. Finally, Evercore reiterated an “outperform” rating and issued a $185.00 price objective on shares of Veeva Systems in a research report on Thursday. Seventeen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $264.04.
View Our Latest Report on VEEV
Veeva Systems Price Performance
Veeva Systems (NYSE:VEEV – Get Free Report) last issued its quarterly earnings data on Wednesday, June 3rd. The technology company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. Veeva Systems had a return on equity of 13.80% and a net margin of 28.44%.The firm had revenue of $882.95 million during the quarter, compared to the consensus estimate of $857.73 million. During the same quarter in the previous year, the company posted $1.97 EPS. The business’s revenue for the quarter was up 16.3% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. Equities analysts anticipate that Veeva Systems will post 6.45 earnings per share for the current fiscal year.
Insider Buying and Selling at Veeva Systems
In other news, Director Priscilla Hung sold 750 shares of the business’s stock in a transaction on Thursday, April 30th. The stock was sold at an average price of $155.64, for a total transaction of $116,730.00. Following the completion of the sale, the director owned 3,253 shares in the company, valued at $506,296.92. The trade was a 18.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Veeva Systems
A number of institutional investors and hedge funds have recently made changes to their positions in the company. Jensen Investment Management Inc. grew its stake in shares of Veeva Systems by 1,924.5% during the third quarter. Jensen Investment Management Inc. now owns 413,213 shares of the technology company’s stock worth $123,100,000 after purchasing an additional 392,802 shares during the period. Alphinity Investment Management Pty Ltd acquired a new stake in shares of Veeva Systems during the third quarter worth $422,241,000. ABN AMRO Bank N.V. acquired a new stake in shares of Veeva Systems during the third quarter worth $246,625,000. Robeco Institutional Asset Management B.V. grew its stake in shares of Veeva Systems by 11.3% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 892,070 shares of the technology company’s stock worth $199,137,000 after purchasing an additional 90,703 shares during the period. Finally, BI Asset Management Fondsmaeglerselskab A S grew its stake in shares of Veeva Systems by 293.4% during the third quarter. BI Asset Management Fondsmaeglerselskab A S now owns 26,979 shares of the technology company’s stock worth $8,037,000 after purchasing an additional 20,121 shares during the period. Institutional investors own 88.20% of the company’s stock.
Trending Headlines about Veeva Systems
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Veeva reported Q1 revenue of about $882.9 million and adjusted EPS of $2.24, both ahead of estimates, showing continued demand and profitability improvement. Veeva Systems (VEEV) Q1 Earnings and Revenues Surpass Estimates
- Positive Sentiment: Management issued Q2 revenue guidance of roughly $902 million-$905 million and EPS guidance of $2.21-$2.22, both above consensus, signaling confidence in near-term growth. Veeva Announces Fiscal 2027 First Quarter Results
- Positive Sentiment: Veeva highlighted AI innovations during the earnings call, which may support future product adoption and help the company deepen its competitive position in life sciences software. Veeva Systems Inc (VEEV) Q1 2027 Earnings Call Highlights: Surpassing Revenue Guidance and Unveiling AI Innovations
- Neutral Sentiment: Several summaries of the results emphasized that the quarter’s headline numbers were strong, but investors are still parsing the full transcript and details behind the outlook. Veeva Systems Inc. (VEEV) Q1 2027 Earnings Call Transcript
- Negative Sentiment: Despite the beat-and-raise report, some coverage noted the shares slipped after the announcement, suggesting the market may have been positioned for strong results or is focused on valuation and broader market sentiment. Veeva Shares Slip Despite Beating Q1 Estimates: Details
Veeva Systems Company Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Further Reading
- Five stocks we like better than Veeva Systems
- Dell’s AI Toll Bridge Is Paved with Record Margins
- As AI Data Breaches Become More Common, This Cybersecurity ETF Is SurgingAI
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
